Advertisement

Advertisement

DE:3OS0 Stock Latest News

Tempest Therapeutics Strengthens Governance and CAR-T Partnership Framework

Company AnnouncementsTempest Therapeutics Strengthens Governance and CAR-T Partnership Framework

Tempest Therapeutics files to sell 9.53M shares of common stock for holders

PremiumThe Fly

Tempest Therapeutics files to sell 9.53M shares of common stock for holders

14d ago

Tempest Therapeutics price target lowered to $7 from $11 at H.C. Wainwright

PremiumThe Fly

Tempest Therapeutics price target lowered to $7 from $11 at H.C. Wainwright

15d ago

Tempest Therapeutics appoints Freda-Smith to board of directors

PremiumThe Fly

Tempest Therapeutics appoints Freda-Smith to board of directors

16d ago

Tempest Therapeutics Expands In Vivo CAR-T Collaboration

PremiumCompany Announcements

Tempest Therapeutics Expands In Vivo CAR-T Collaboration

22d ago

Tempest Therapeutics Adjourns Meeting on Governance Changes

PremiumCompany AnnouncementsTempest Therapeutics Adjourns Meeting on Governance Changes

23d ago

Tempest Therapeutics Announces New Private Warrant Financing

Company Announcements

Tempest Therapeutics Announces New Private Warrant Financing

24d ago

Tempest Therapeutics enters exclusive option agreement with Hebei Senlang

The Fly

Tempest Therapeutics enters exclusive option agreement with Hebei Senlang

24d ago

Tempest Therapeutics announces $7.5M private placement

PremiumThe Fly

Tempest Therapeutics announces $7.5M private placement

28d ago

Tempest Therapeutics Announces New Chief Financial Officer

PremiumCompany Announcements

Tempest Therapeutics Announces New Chief Financial Officer

2M ago

Tempest Therapeutics files to sell 8.91M shares of common stock for holders

PremiumThe Fly

Tempest Therapeutics files to sell 8.91M shares of common stock for holders

2M ago

Tempest Therapeutics Adjourns Special Stockholder Meeting Again

PremiumCompany Announcements

Tempest Therapeutics Adjourns Special Stockholder Meeting Again

2M ago

Tempest Therapeutics Secures Flexible $50 Million Equity Facility

PremiumCompany AnnouncementsTempest Therapeutics Secures Flexible $50 Million Equity Facility

2M ago

Tempest Therapeutics Adjourns Vote on Governance Changes

Company Announcements

Tempest Therapeutics Adjourns Vote on Governance Changes

2M ago

Tempest Therapeutics inks China in vivo CAR-T deal

Company Announcements

Tempest Therapeutics inks China in vivo CAR-T deal

3M ago

Rani Therapeutics appoints Nicholas Maestas as CFO

PremiumThe Fly

Rani Therapeutics appoints Nicholas Maestas as CFO

3M ago

Tempest Therapeutics registers to sell 2.43M shares of common stock for holders

PremiumThe Fly

Tempest Therapeutics registers to sell 2.43M shares of common stock for holders

3M ago

Tempest Stockholders Approve Warrant-Related Share Issuances

PremiumCompany Announcements

Tempest Stockholders Approve Warrant-Related Share Issuances

4M ago

Tempest Therapeutics Announces CFO Transition and Board Changes

PremiumCompany Announcements

Tempest Therapeutics Announces CFO Transition and Board Changes

4M ago

Tempest Therapeutics Executes Warrant-Inducement Equity Financing Deal

PremiumCompany AnnouncementsTempest Therapeutics Executes Warrant-Inducement Equity Financing Deal

4M ago

Tempest Therapeutics Announces Resignation of Board Director

Company Announcements

Tempest Therapeutics Announces Resignation of Board Director

4M ago

Tempest Therapeutics Faces Nasdaq Listing and Governance Risks

Company Announcements

Tempest Therapeutics Faces Nasdaq Listing and Governance Risks

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >